Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

CTT begins Phase I trial of CTT1057 to treat men with high-risk metastatic prostate cancer

Go Top